Home/Filings/4/0001567619-21-011806
4//SEC Filing

Peterson Amy C. 4

Accession 0001567619-21-011806

CIK 0001501989other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 1:07 PM ET

Size

4.8 KB

Accession

0001567619-21-011806

Insider Transaction Report

Form 4
Period: 2021-05-31
Peterson Amy C.
EVP, Chief Development Officer
Transactions
  • Award

    Common Stock

    2021-05-31$6.09/sh+3,320$20,2066,421 total
Footnotes (1)
  • [F1]3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0001682735

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 1:07 PM ET
Size
4.8 KB